< BACK

15 Dec Erectafil: Comprehensive Insights

Posted at 18:13h in general by
Characteristic Details
Active Ingredient Tadalafil
Dosage Forms 5 mg, 10 mg, 20 mg
Administration Route Oral
Onset of Action 30-60 minutes
Duration of Action Up to 36 hours
Peak Plasma Concentration 2 hours post-dose
Learn More about Erectafil

Pharmacokinetics

Erectafil 20 mg showcases its efficacy through robust pharmacokinetic properties. Once administered orally, Tadalafil is absorbed rapidly, with peak plasma concentrations reached within two hours. This ensures prompt therapeutic action. The drug displays a half-life of approximately 17.5 hours, enabling prolonged activity. The bioavailability of Tadalafil is not influenced by food intake, which permits flexible dosing. Metabolism occurs primarily in the liver, mediated by the CYP3A4 enzyme. Tadalafil is excreted as metabolites in feces and urine. Renal and hepatic impairments may require dosage adjustments to maintain safe therapeutic levels.

Dosage Information

Erectafil comes in three dosing options: 5 mg, 10 mg, and 20 mg. The initial dose usually recommended is 10 mg, taken prior to anticipated sexual activity. Depending on individual response and tolerability, this dose may be increased to 20 mg or reduced to 5 mg. Daily dosing with the 5 mg variant is advised for individuals anticipating frequent use, ensuring consistent therapeutic plasma levels. The higher doses should not be taken more than once per day to avoid adverse reactions. It is crucial for patients to adhere to prescribed dosing schedules for optimal efficacy and safety.

FDA-Approved Indications

The FDA endorses Erectafil for the management of erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). Its effectiveness in ED stems from its ability to enhance penile blood flow by inhibiting phosphodiesterase type 5 (PDE5). For BPH, it aids in alleviating urinary symptoms through smooth muscle relaxation in the prostate and bladder. Erectafil has shown versatility, allowing concurrent treatment of both conditions when present. This dual indication enhances patient compliance and simplifies therapeutic regimens.

Erectafil Interactions

Drug interactions can impact Erectafil’s performance. Co-administration with nitrates is contraindicated due to the risk of severe hypotension. Caution is advised when used with alpha-blockers, antihypertensives, or alcohol. These combinations may potentiate blood pressure-lowering effects. Tadalafil metabolism may be altered by inhibitors or inducers of CYP3A4, such as ketoconazole or rifampicin, respectively. Patients should inform their healthcare provider of all medications they are taking to avoid unwanted interactions.

Adverse Effects

Common side effects of Erectafil include headache, dyspepsia, back pain, and nasal congestion. These are usually transient and mild. Rare but serious adverse reactions can occur, including priapism, sudden hearing loss, and vision changes. Patients should seek immediate medical attention if these occur. Adjustments in dosage or discontinuation may be necessary for those experiencing intolerable side effects. Monitoring by healthcare professionals ensures prompt identification and management of potential complications.

Erectafil Over The Counter

Currently, Erectafil is not available over the counter. It remains a prescription-only medication due to its need for medical oversight. This ensures appropriate use, minimizing the risk of side effects and interactions. Patients require evaluation by healthcare providers to determine suitability. Prescription regulation maintains therapeutic integrity, ensuring Erectafil’s benefits are realized safely. Future developments may alter its prescription status, but as of now, patient safety takes precedence.

Factor Details
Elimination Feces (61%), Urine (36%)
Metabolic Pathway CYP3A4-mediated
Half-life 17.5 hours

Information taken from: